Skip to main content
SpringerLink
Log in

Clinical analysis of pyoderma gangrenosum: 41 Japanese cases over 15 years

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al Ghazal P, Herberger K, Schaller J, et al. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicenter analysis in 259 patients. Orphanet J Rare Dis 2013; 8:136.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 2012; 132: 2166–70.

    Article  PubMed  CAS  Google Scholar 

  3. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007; 33: 787–802.

    Article  PubMed  Google Scholar 

  4. Papp M, Norman GL, Altorjay I, et al. Utility of serological markers in inflammatory bowel disease: gadget or magic? World J Gastroenterol 2007; 13: 2028–36.

    Article  PubMed  PubMed Central  Google Scholar 

  5. De Boysson H, Silva NM, de Moreuil C, et al. Neutrophilic dermatoses in antineutrophil cytoplasmic antibody-associated vasculitis: a French Multicenter study of 17 cases and literature review. Medicine 2016; 95: e2957.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Reumaux D, Duthilleul P, Roos D. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum Immunol 2004; 65: 1–12.

    Article  PubMed  CAS  Google Scholar 

  7. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006; 55: 505–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Marzano AV, Fanoni D, Antiga E, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 2014; 178: 48–56.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Marzano AV, Damiani G, Ceccherini I, et al. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 2017; 176: 1588–98.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Fukushima Medical University, Fukushima, Japan

    Nobuyuki Kikuchi & Toshiyuki Yamamoto

Authors
  1. Nobuyuki Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobuyuki Kikuchi.

Electronic supplementary material

Table S1.

Therapy for PG.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kikuchi, N., Yamamoto, T. Clinical analysis of pyoderma gangrenosum: 41 Japanese cases over 15 years. Eur J Dermatol 28, 230–232 (2018). https://doi.org/10.1684/ejd.2017.3204

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2017.3204

Search

Navigation